TARO logo

TARO Cash From Operations

Annual CFO

$124.56 M
+$92.81 M+292.30%

March 31, 2024

Summary

Performance

1-Year Change

+292.3%

3-Year Change

+172.13%

5-Year Change

-61.52%

15-Year Change

-71.53%

TARO Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$437.54 M
TARO annual cash flow from operations is currently -71.53% below its historical high of $437.54 million

3-Year Low

-$158.70 M

Earnings dates

Last Annual Earnings Report Date

Mar 31, 2024
TARO previous annual earnings announcement was published on Mar 31, 2024

Next Annual Earnings Report Date

N/A
TARO next annual earnings announcement has not yet been scheduled

OtherTAROcash flowmetrics:

Annual CFI

$84.34 M
TARO annual cash flow from investing activities is $84.34 million

Annual CFF

-
TARO annual cash flow from financing activities value is unknown

Annual FCF

$70.34 M
TARO annual free cash flow is $70.34 million

Annual CAPEX

$54.22 M
TARO annual capital expenditures is $54.22 million

Quarterly CFO

$38.34 M
+$7.41 M+23.97%

March 31, 2024

Summary

Performance

3-Month Change

+23.97%

1-Year Change

+23.97%

3-Year Change

-24.91%

5-Year Change

-61.14%

TARO Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$213.95 M
TARO quarterly cash flow from operations is currently -82.08% below its historical high of $213.95 million

3-Year Low

-$191.93 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
TARO previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
TARO next earnings announcement has not yet been scheduled

OtherTAROcash flowmetrics:

Quarterly CFI

-$57.20 M
TARO quarterly cash flow from investing activities is -$57.20 million

Quarterly CFF

-
TARO quarterly cash flow from financing activities value is unknown

Quarterly FCF

$32.45 M
TARO quarterly free cash flow is $32.45 million

Quarterly CAPEX

$5.89 M
TARO quarterly capital expenditures is $5.89 million

TTM CFO

$124.56 M
-$18.31 M-12.82%

March 31, 2024

Summary

Performance

3-Month Change

-12.82%

1-Year Change

-12.82%

3-Year Change

+172.13%

5-Year Change

-55.61%

TARO TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$475.87 M
TARO TTM cash flow from operations is currently -73.83% below its historical high of $475.87 million

3-Year Low

-$260.72 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
TARO previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
TARO next earnings announcement has not yet been scheduled

OtherTAROcash flowmetrics:

TTM CFI

$84.34 M
TARO TTM cash flow from investing activities is $84.34 million

TTM CFF

-
TARO TTM cash flow from financing activities value is unknown

TTM FCF

$70.34 M
TARO TTM free cash flow is $70.34 million

TTM CAPEX

$54.22 M
TARO TTM capital expenditures is $54.22 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

TARO Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+292.3%+24.0%-12.8%
3 y3 years+172.1%-24.9%+172.1%
5 y5 years-61.5%-61.1%-55.6%

TARO Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-227.4%-32.3%-600.6%-12.8%-309.3%
5 y5-year-61.5%-227.4%-61.1%-600.6%-55.6%-309.3%
alltimeall time-71.5%-227.4%-82.1%-600.6%-73.8%-309.3%

Taro Pharmaceutical Industries Cash From Operations History

DateAnnualQuarterlyTTM
Mar 2024
$124.56 M(+292.3%)
$38.34 M(+24.0%)
$124.56 M(-12.8%)
Dec 2023
-
$30.93 M(-34.9%)
$142.87 M(+14.6%)
Sep 2023
-
$47.52 M(+511.0%)
$124.71 M(+27.8%)
Jun 2023
-
$7.78 M(-86.3%)
$97.56 M(+207.3%)
Mar 2023
$31.75 M(-120.0%)
$56.65 M(+343.7%)
$31.75 M(+94.1%)
Dec 2022
-
$12.77 M(-37.3%)
$16.36 M(-108.7%)
Sep 2022
-
$20.36 M(-135.1%)
-$188.34 M(-27.8%)
Jun 2022
-
-$58.03 M(-240.6%)
-$260.72 M(+64.3%)
Mar 2022
-$158.70 M(-446.7%)
$41.26 M(-121.5%)
-$158.70 M(+6.6%)
Dec 2021
-
-$191.93 M(+269.0%)
-$148.90 M(-273.4%)
Sep 2021
-
-$52.02 M(-218.2%)
$85.89 M(+234.8%)
Jun 2021
-
$43.99 M(-13.8%)
$25.65 M(-44.0%)
Mar 2021
$45.77 M(-83.1%)
$51.05 M(+19.1%)
$45.77 M(+3.3%)
Dec 2020
-
$42.86 M(-138.2%)
$44.31 M(-55.7%)
Sep 2020
-
-$112.26 M(-275.1%)
$100.10 M(-60.5%)
Jun 2020
-
$64.11 M(+29.3%)
$253.11 M(-6.8%)
Mar 2020
$271.61 M(-16.1%)
$49.60 M(-49.7%)
$271.61 M(-3.2%)
Dec 2019
-
$98.65 M(+142.1%)
$280.59 M(-3.1%)
Sep 2019
-
$40.75 M(-50.7%)
$289.42 M(-10.6%)
Jun 2019
-
$82.60 M(+41.0%)
$323.87 M(+0.1%)
Mar 2019
$323.71 M(+0.0%)
$58.58 M(-45.5%)
$323.71 M(-10.8%)
Dec 2018
-
$107.48 M(+42.9%)
$363.02 M(+5.9%)
Sep 2018
-
$75.21 M(-8.8%)
$342.64 M(+2.8%)
Jun 2018
-
$82.44 M(-15.8%)
$333.46 M(+3.0%)
Mar 2018
$323.69 M(-26.0%)
$97.89 M(+12.4%)
$323.69 M(-5.6%)
Dec 2017
-
$87.10 M(+31.9%)
$342.88 M(-10.6%)
Sep 2017
-
$66.03 M(-9.1%)
$383.56 M(-15.6%)
Jun 2017
-
$72.67 M(-37.9%)
$454.24 M(+3.8%)
Mar 2017
$437.54 M(+10.7%)
$117.08 M(-8.4%)
$437.54 M(-8.1%)
Dec 2016
-
$127.78 M(-6.5%)
$475.87 M(+3.8%)
Sep 2016
-
$136.71 M(+144.3%)
$458.48 M(+19.8%)
Jun 2016
-
$55.97 M(-64.0%)
$382.83 M(-3.1%)
Mar 2016
$395.13 M(-2.9%)
$155.42 M(+40.8%)
$395.13 M(-12.9%)
Dec 2015
-
$110.39 M(+80.8%)
$453.66 M(+3.1%)
Sep 2015
-
$61.06 M(-10.6%)
$439.96 M(+0.1%)
Jun 2015
-
$68.27 M(-68.1%)
$439.32 M(+8.0%)
Mar 2015
$406.79 M
$213.95 M(+121.3%)
$406.79 M(+47.0%)
Dec 2014
-
$96.69 M(+60.0%)
$276.77 M(-5.9%)
DateAnnualQuarterlyTTM
Sep 2014
-
$60.42 M(+69.1%)
$294.12 M(-10.6%)
Jun 2014
-
$35.73 M(-57.4%)
$328.97 M(-8.0%)
Mar 2014
$357.64 M(+43.8%)
$83.93 M(-26.4%)
$357.64 M(+2.4%)
Dec 2013
-
$114.03 M(+19.7%)
$349.27 M(+6.9%)
Sep 2013
-
$95.27 M(+47.9%)
$326.85 M(+11.2%)
Jun 2013
-
$64.41 M(-14.7%)
$293.85 M(+18.2%)
Mar 2013
$248.65 M(+218.4%)
$75.55 M(-17.5%)
$248.65 M(+43.6%)
Dec 2012
-
$91.61 M(+47.1%)
$173.10 M(+21.0%)
Sep 2012
-
$62.27 M(+224.2%)
$143.00 M(+0.1%)
Jun 2012
-
$19.21 M(-68.8%)
$142.91 M(-21.2%)
Mar 2012
$78.09 M(-57.0%)
-
-
Dec 2011
$181.41 M(+157.4%)
$61.52 M(-1.1%)
$181.41 M(+19.4%)
Sep 2011
-
$62.19 M(+86.5%)
$151.93 M(+45.9%)
Jun 2011
-
$33.35 M(+36.9%)
$104.13 M(+31.8%)
Mar 2011
-
$24.36 M(-24.0%)
$78.99 M(+12.1%)
Dec 2010
$70.48 M(+10.3%)
$32.04 M(+122.8%)
$70.48 M(+83.3%)
Sep 2010
-
$14.38 M(+75.1%)
$38.44 M(+59.8%)
Jun 2010
-
$8.21 M(-48.2%)
$24.06 M(+51.8%)
Mar 2010
-
$15.85 M
$15.85 M
Dec 2009
$63.92 M(-14.6%)
-
-
Dec 2008
$74.88 M(+6399.7%)
-
-
Dec 2007
$1.15 M(-104.7%)
-
-
Dec 2006
-$24.76 M(-242.5%)
-
-
Dec 2005
$17.38 M(-1060.2%)
-
-
Dec 2004
-$1.81 M(-134.4%)
-
-
Dec 2003
$5.26 M(-82.3%)
-
-
Dec 2002
$29.64 M(+8.2%)
-
-
Dec 2001
$27.39 M(+334.9%)
-
-
Dec 2000
$6.30 M(+66.1%)
-
-
Dec 1999
$3.79 M(+40.4%)
-
-
Dec 1998
$2.70 M(-6.9%)
-
-
Dec 1997
$2.90 M(+163.6%)
-
-
Dec 1996
$1.10 M(+57.1%)
-
-
Dec 1995
$700.00 K(+75.0%)
-
-
Dec 1994
$400.00 K(+300.0%)
-
-
Dec 1993
$100.00 K(-116.7%)
-
-
Dec 1992
-$600.00 K(+100.0%)
-
-
Dec 1991
-$300.00 K
-
-

FAQ

  • What is Taro Pharmaceutical Industries annual cash flow from operations?
  • What is the all time high annual CFO for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries annual CFO year-on-year change?
  • What is Taro Pharmaceutical Industries quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries quarterly CFO year-on-year change?
  • What is Taro Pharmaceutical Industries TTM cash flow from operations?
  • What is the all time high TTM CFO for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries TTM CFO year-on-year change?

What is Taro Pharmaceutical Industries annual cash flow from operations?

The current annual CFO of TARO is $124.56 M

What is the all time high annual CFO for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high annual cash flow from operations is $437.54 M

What is Taro Pharmaceutical Industries annual CFO year-on-year change?

Over the past year, TARO annual cash flow from operations has changed by +$92.81 M (+292.30%)

What is Taro Pharmaceutical Industries quarterly cash flow from operations?

The current quarterly CFO of TARO is $38.34 M

What is the all time high quarterly CFO for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high quarterly cash flow from operations is $213.95 M

What is Taro Pharmaceutical Industries quarterly CFO year-on-year change?

Over the past year, TARO quarterly cash flow from operations has changed by +$7.41 M (+23.97%)

What is Taro Pharmaceutical Industries TTM cash flow from operations?

The current TTM CFO of TARO is $124.56 M

What is the all time high TTM CFO for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high TTM cash flow from operations is $475.87 M

What is Taro Pharmaceutical Industries TTM CFO year-on-year change?

Over the past year, TARO TTM cash flow from operations has changed by -$18.31 M (-12.82%)